EFFECTIVENESS AND SAFETY OF TOFACITINIB IN PATIENTS WITH CHRONIC ANTI-TNF REFRACTORY ULCERATIVE PROCTITIS: A MULTICENTER COHORT STUDY FROM THE GETAID

Mathieu Uzzan  ¹     Pauline Wils  ²     Alexandre Nuzzo  ³     Aurelien Amiot  ⁴     Bénédicte Caron  ⁵     Alban Benezech  ⁶     Anthony Buisson  ⁷     Guillaume Bouguen  ⁸     Catherine Le Berre  ⁹     Catherine Reenaers  ¹⁰     Guillaume Le Cosquer  ¹¹     Guillaume Savoye  ¹²     Maeva CHARKAOUI  ¹³     Mathias Vidon  ¹⁴     Mélanie Serrero  ¹⁵     Mathurin Fumery  ¹⁶     Julien Kirchgesner  ¹⁷     Yoram Bouhnik  ^18    
1 Hopital Mondor, Créteil, France
² CHRU Lille, Lille Cedex, France
³ Beaujon Hospital, Paris, France
⁴ Henri Bicetre Hospital, APHP, Kremlin Bicetre, France
⁵ CHU Nancy, Nancy, France
⁶ CH Avignon, Avignon, France
⁷ CHU Estaing Clermont-Ferrand, Clermont-ferrand, France
⁸ CHU Pontchaillou, Rennes, France
⁹ CHU Nantes, Nantes, France
¹⁰ Assistants en Formation Gastro, Réseau Ulg, Lantremange, Belgium
¹¹ CHU Toulouse, Toulouse, France
¹² Hopiaux de Rouen, Rouen, France
¹³ CHU Dijon, Paris Cedex 12, France
¹⁴ CHI Creteil, Creteil, France
¹⁵ Hopital Nord, Marseille, France
¹⁶ Amiens University Hospital, Amiens, France
¹⁷ Saint-Antoine Hospital, Paris, France
¹⁸ CHU Beaujon, Dept. of IBD and Nutrition, Clichy, France

Topic
IBD

Session
Medical therapy of IBD: Facts and challenges (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)